Terbogrel
id:
terbogrel-302-9879039
title:
Terbogrel
text:
Terbogrel (INN) is an experimental drug that has been studied for its potential to prevent the vasoconstricting and platelet-aggregating action of thromboxanes. Terbogrel is an orally available thromboxane A2 receptor antagonist and a thromboxane A synthase inhibitor. The drug was developed by Boehringer Ingelheim. A phase 2 clinical trial of terbogrel was discontinued due to its induction of leg pain.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Terbogrel
date created:
date modified:
2022-11-07T15:53:42Z
main entity:
{"identifier":"Q7701660","url":"https://www.wikidata.org/entity/Q7701660"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b2/Terbogrel.svg","width":512,"height":453}
fields total:
13
integrity:
15